Currently, there is no clinical guidance recommending the combined use of semaglutide and tirzepatide
Switching to a lower maintenance dose, rather than stopping completely, is a common approach
A monthly supply of Ozempic or Wegovy can cost more than one thousand dollars without insurance coverage, while compounded alternatives are often a few hundred dollars
Tirzepatide (Mounjaro) Tirzepatide is the first in its class of dual GIP/GLP-1 receptor agonists
However, an increasing number of research studies are demonstrating that these substances also have neuroprotective effects in neurodegenerative diseases, mental disorders, and other brain conditions
This variation in definition also adds to the complexity of research on the metabolic characteristics of MCFAs [187]